Insider Transactions in Q4 2022 at Enzo Biochem Inc (ENZ)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2022
|
Kara Cannon Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,600
+45.49%
|
-
|
|
Dec 16
2022
|
James G. Wolf |
BUY
Conversion of derivative security
|
Direct |
33,700
+0.88%
|
$67,400
$2.5 P/Share
|
|
Dec 15
2022
|
James G. Wolf |
BUY
Conversion of derivative security
|
Direct |
85,100
+2.2%
|
$170,200
$2.5 P/Share
|
|
Dec 14
2022
|
James G. Wolf |
BUY
Conversion of derivative security
|
Direct |
136,200
+3.55%
|
$272,400
$2.5 P/Share
|
|
Nov 23
2022
|
Hamid Erfanian Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
100,000
+21.07%
|
$100,000
$1.97 P/Share
|
|
Nov 21
2022
|
James G. Wolf |
BUY
Conversion of derivative security
|
Direct |
24,700
+0.69%
|
$49,400
$2.5 P/Share
|
|
Nov 17
2022
|
James G. Wolf |
BUY
Conversion of derivative security
|
Direct |
300
+0.01%
|
$600
$2.5 P/Share
|
|
Nov 01
2022
|
James G. Wolf |
BUY
Open market or private purchase
|
Indirect |
8,500
+1.03%
|
$17,000
$2.15 P/Share
|
|
Oct 31
2022
|
James G. Wolf |
BUY
Open market or private purchase
|
Indirect |
14,500
+3.38%
|
$29,000
$2.15 P/Share
|